Loading...
XPAR
EAPI
Market cap81mUSD
Oct 09, Last price  
0.77EUR
1D
1.20%
1Q
-39.52%
IPO
-94.52%
Name

Euroapi SAS

Chart & performance

D1W1MN
XPAR:EAPI chart
P/E
—
P/S
0.09
EPS
—
Div yield, %
—
Shrs. gr., 5y
0.14%
Rev. gr., 5y
-2.13%
Revenues
848m
-7.72%
915,800,000944,600,000892,800,000980,900,0001,018,900,000919,200,000848,200,000
Net income
-211m
L+61.72%
2,500,000-6,300,000-8,100,000-15,000,000-189,700,000-130,600,000-211,200,000
CFO
126m
+2.12%
34,900,00096,800,00071,500,00044,800,0005,100,000122,900,000125,500,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in 2021 and headquartered in Paris, France, Euroapi SA specializes in the end-to-end process, from development and manufacturing to marketing and distribution, of active pharmaceutical ingredients (APIs) and various intermediary compounds. These essential materials are then utilized in the formulation of a wide array of medicinal products for both human and veterinary applications.

Related entities

Subsidiaries
EUROAPI FRANCE
URL
https://www.euroapi.com/
IPO date
May 06, 2022
Employees
3,450
Domiciled in
FR
Incorporated in
FR
Headquarters & legal address
32 RUE ALEXANDRE DUMAS
PARIS 75011
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT